This announcement is a separate document:
Actinogen Medical Ltd: ACW XanaCIDD phase 2a trial topline results
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.